A phase I trial of an oral subtype-selective histone deacetylase inhibitor,chidamide,in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer | |
Hu Xingsheng; Wang Lin; Lin Lin; Han Xiaohong; Dou Guifang; Meng Zhiyun; Shi Yuankai | |
2016 | |
卷号 | 28期号:4页码:444-451 |
关键词 | Chidamide HDAC inhibitor phase I paclitaxel and carboplatin non-small cell lung cancer |
URL标识 | 查看原文 |
收录类别 | ISTIC ; CSCD |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6386172 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Hu Xingsheng,Wang Lin,Lin Lin,et al. A phase I trial of an oral subtype-selective histone deacetylase inhibitor,chidamide,in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer[J],2016,28(4):444-451. |
APA | Hu Xingsheng.,Wang Lin.,Lin Lin.,Han Xiaohong.,Dou Guifang.,...&Shi Yuankai.(2016).A phase I trial of an oral subtype-selective histone deacetylase inhibitor,chidamide,in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.,28(4),444-451. |
MLA | Hu Xingsheng,et al."A phase I trial of an oral subtype-selective histone deacetylase inhibitor,chidamide,in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer".28.4(2016):444-451. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论